Innoviva, Inc. (INVA)
22.14
-0.59
(-2.60%)
USD |
NASDAQ |
Mar 05, 15:01
Innoviva Price : 22.14 for March 5, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Merck & Co., Inc. | 115.79 |
| Nektar Therapeutics | 71.55 |
| Regeneron Pharmaceuticals, Inc. | 762.32 |
| Oramed Pharmaceuticals, Inc. | 3.29 |
| Theravance Biopharma, Inc. | 13.59 |
Price Related Metrics
| PE Ratio | 7.246 |
| PS Ratio | 4.132 |
| PEG Ratio | 0.0054 |
| Price to Book Value | 1.411 |
| Price to Free Cash Flow | 8.972 |
| Earnings Yield | 13.80% |
| Market Cap | 1.655B |
| PEGY Ratio | 0.0054 |
| Operating PE Ratio | 10.73 |
| Normalized PE Ratio | 11.31 |